2-105386397-G-A

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The ENST00000530340.6(FHL2):​c.120C>T​(p.Cys40=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00207 in 1,614,124 control chromosomes in the GnomAD database, including 67 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.011 ( 37 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 30 hom. )

Consequence

FHL2
ENST00000530340.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0990
Variant links:
Genes affected
FHL2 (HGNC:3703): (four and a half LIM domains 2) This gene encodes a member of the four-and-a-half-LIM-only protein family. Family members contain two highly conserved, tandemly arranged, zinc finger domains with four highly conserved cysteines binding a zinc atom in each zinc finger. This protein is thought to have a role in the assembly of extracellular membranes. Also, this gene is down-regulated during transformation of normal myoblasts to rhabdomyosarcoma cells and the encoded protein may function as a link between presenilin-2 and an intracellular signaling pathway. Multiple alternatively spliced variants encoding different isoforms have been identified. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 2-105386397-G-A is Benign according to our data. Variant chr2-105386397-G-A is described in ClinVar as [Benign]. Clinvar id is 48320.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-105386397-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.099 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.011 (1677/152266) while in subpopulation AFR AF= 0.0386 (1602/41544). AF 95% confidence interval is 0.037. There are 37 homozygotes in gnomad4. There are 817 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1677 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FHL2NM_001318895.3 linkuse as main transcriptc.120C>T p.Cys40= synonymous_variant 3/7 ENST00000530340.6 NP_001305824.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FHL2ENST00000530340.6 linkuse as main transcriptc.120C>T p.Cys40= synonymous_variant 3/71 NM_001318895.3 ENSP00000433567 P1Q14192-1

Frequencies

GnomAD3 genomes
AF:
0.0110
AC:
1676
AN:
152148
Hom.:
36
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0387
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00334
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00717
GnomAD3 exomes
AF:
0.00287
AC:
721
AN:
251340
Hom.:
16
AF XY:
0.00194
AC XY:
264
AN XY:
135836
show subpopulations
Gnomad AFR exome
AF:
0.0402
Gnomad AMR exome
AF:
0.00136
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000653
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.0000968
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.00114
AC:
1665
AN:
1461858
Hom.:
30
Cov.:
31
AF XY:
0.000920
AC XY:
669
AN XY:
727230
show subpopulations
Gnomad4 AFR exome
AF:
0.0392
Gnomad4 AMR exome
AF:
0.00206
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000812
Gnomad4 FIN exome
AF:
0.0000187
Gnomad4 NFE exome
AF:
0.000123
Gnomad4 OTH exome
AF:
0.00184
GnomAD4 genome
AF:
0.0110
AC:
1677
AN:
152266
Hom.:
37
Cov.:
32
AF XY:
0.0110
AC XY:
817
AN XY:
74462
show subpopulations
Gnomad4 AFR
AF:
0.0386
Gnomad4 AMR
AF:
0.00333
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000415
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000103
Gnomad4 OTH
AF:
0.00710
Alfa
AF:
0.00488
Hom.:
5
Bravo
AF:
0.0126
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.000237

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMay 17, 2012Cys40Cys in exon 2 of FHL2: This variant is not expected to have clinical signif icance as it does not lead to an amino acid change and has been observed in 3.8% (142/3738) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS). -
Primary dilated cardiomyopathy Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
10
DANN
Benign
0.64
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs11537578; hg19: chr2-106002854; COSMIC: COSV59080186; COSMIC: COSV59080186; API